There’s No Getting Around Silk Road Medical Inc (NASDAQ: SILK) Success

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Yahoo Finance discussed the stock recently as it posted Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

SILK belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. The current market capitalization of Silk Road Medical Inc is $721.51M. A total of 0.64 million shares were traded on the day, compared to an average of 882.00K shares.

In the most recent transaction, Ballinger Kevin J. bought 11,700 shares of SILK for 16.99 per share on Mar 05 ’24. After the transaction, the Director now owns 17,807 company shares. In a previous transaction on Mar 05 ’24, Buchanan Lucas W. sold 9,877 shares at 17.17 per share. SILK shares that COO/CFO owns now total 500,925.

Among the insiders who sold shares, Davis Andrew S. disposed of 5,481 shares on Mar 05 ’24 at a per-share price of $17.17. This resulted in the Chief Commercial Officer holding 287,773 shares of SILK after the transaction. In another insider transaction, Ruedy Richard sold 3,800 shares at $17.17 per share on Mar 05 ’24. Company shares held by the EVPClin&Reg.Affairs&QA now total 205,711.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SILK has a high of $46.57 and a low of $6.08.

As of this writing, SILK has an earnings estimate of -$0.4 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.36 per share and a lower estimate of -$0.42. The company reported an EPS of -$0.33 in the last quarter, which was 5.70% higher than expectations of -$0.35.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SILK’s latest balance sheet shows that the firm has $110.23M in Cash & Short Term Investments as of fiscal 2021. There were $49.98M in debt and $26.09M in liabilities at the time. Its Book Value Per Share was $3.86, while its Total Shareholder’s Equity was $79.24M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SILK is Buy with a score of 3.50.

Most Popular

Related Posts